Transgene SA
PAR:TNG
Transgene SA
Cash from Investing Activities
Transgene SA
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Transgene SA
PAR:TNG
|
Cash from Investing Activities
€34.6m
|
CAGR 3-Years
25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Valneva SE
PAR:VLA
|
Cash from Investing Activities
€69.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nanobiotix SA
PAR:NANO
|
Cash from Investing Activities
-€349k
|
CAGR 3-Years
-46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-6%
|
|
Innate Pharma SA
PAR:IPH
|
Cash from Investing Activities
€20.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Cellectis SA
PAR:ALCLS
|
Cash from Investing Activities
-$15.5m
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-36%
|
|
Abivax SA
PAR:ABVX
|
Cash from Investing Activities
-€8.1m
|
CAGR 3-Years
-141%
|
CAGR 5-Years
-100%
|
CAGR 10-Years
N/A
|
See Also
What is Transgene SA's Cash from Investing Activities?
Cash from Investing Activities
34.6m
EUR
Based on the financial report for Dec 31, 2023, Transgene SA's Cash from Investing Activities amounts to 34.6m EUR.
What is Transgene SA's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
25%
Over the last year, the Cash from Investing Activities growth was 71%. The average annual Cash from Investing Activities growth rates for Transgene SA have been 25% over the past three years .